Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Treatment option(s) for pulmonary lymphangioleiomyomatosis: progress and current challenges.

Krymskaya VP.

Am J Respir Cell Mol Biol. 2012 May;46(5):563-5. doi: 10.1165/rcmb.2011-0381ED. No abstract available.

2.

A current viewpoint of lymphangioleiomyomatosis supporting immunotherapeutic treatment options.

Dilling DF, Gilbert ER, Picken MM, Eby JM, Love RB, Le Poole IC.

Am J Respir Cell Mol Biol. 2012 Jan;46(1):1-5. doi: 10.1165/rcmb.2011-0215TR. Review.

PMID:
21940815
3.

[Pulmonary lymphangioleiomyomatosis].

Santos AC, Bárbara C, Mendes B, Gomes MJ, Amaral-Marques R.

Acta Med Port. 1994 Feb;7(2):103-6. Review. Portuguese.

4.

[Guide to the treatment and care of lymphangioleiomyomatosis].

Hayashida M.

Nihon Kokyuki Gakkai Zasshi. 2008 Jun;46(6):428-31. Review. Japanese. No abstract available.

PMID:
18592985
5.

Lymphangioleiomyomatosis.

Kitaichi M, Izumi T.

Curr Opin Pulm Med. 1995 Sep;1(5):417-24. Review.

PMID:
9363104
6.

The changing face of a rare disease: lymphangioleiomyomatosis.

Harari S, Torre O, Cassandro R, Moss J.

Eur Respir J. 2015 Nov;46(5):1471-85. doi: 10.1183/13993003.00412-2015. Epub 2015 Sep 24. Review.

7.

[Lymphangioleiomyomatosis].

Minami H, Sakai S.

Ryoikibetsu Shokogun Shirizu. 1994;(4):188-91. Review. Japanese. No abstract available.

PMID:
8007126
8.

Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

Johnson S.

Thorax. 1999 Mar;54(3):254-64. Review. No abstract available.

9.

Lymphangioleiomyomatosis.

Kelly J, Moss J.

Am J Med Sci. 2001 Jan;321(1):17-25. Review.

PMID:
11202475
10.

Update on diffuse parenchymal lung disease.

Harari S, Caminati A.

Eur Respir Rev. 2010 Jun;19(116):97-108. doi: 10.1183/09059180.00002510. Review. No abstract available.

11.

Lymphangioleiomyomatosis.

Johnson SR, Taveira-DaSilva AM, Moss J.

Clin Chest Med. 2016 Sep;37(3):389-403. doi: 10.1016/j.ccm.2016.04.002. Review.

PMID:
27514586
12.

Pulmonary lymphangioleiomyomatosis: literature update.

Valentín-Mendoza S, Nieves-Nieves J, Fernández-Medero R, Fernández-Gonzales R, Adorno-Fontánez J, Adorno-Fontánez E.

Bol Asoc Med P R. 2013;105(3):64-9. Review.

PMID:
24282925
13.

The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells.

Pacheco-Rodriguez G, Moss J.

Crit Rev Immunol. 2010;30(4):387-94. Review.

14.

Lymphangioleiomyomatosis.

Taveira-DaSilva AM, Steagall WK, Moss J.

Cancer Control. 2006 Oct;13(4):276-85. Review.

15.

[Lymphangioleiomyomatosis: recent progress in diagnosis and treatment].

Xu KF, Zhu YJ.

Zhonghua Jie He He Hu Xi Za Zhi. 2008 Sep;31(9):690-1. Review. Chinese. No abstract available.

PMID:
19080575
16.

Lymphangioleiomyomatosis: A review.

Hohman DW, Noghrehkar D, Ratnayake S.

Eur J Intern Med. 2008 Jul;19(5):319-24. doi: 10.1016/j.ejim.2007.10.015. Epub 2007 Dec 26. Review.

PMID:
18549932
17.

Lymphangioleiomyomatosis: a case report and review of the literature.

Bearz A, Rupolo M, Canzonieri V, Balestreri L, La Mura N, Berretta M, Colussi AM, Frustaci S.

Tumori. 2004 Sep-Oct;90(5):528-31. Review.

PMID:
15656345
18.

Pulmonary hypertension complicating interstitial lung disease and COPD.

Shino MY, Lynch JP 3rd, Saggar R, Abtin F, Belperio JA, Saggar R.

Semin Respir Crit Care Med. 2013 Oct;34(5):600-19. doi: 10.1055/s-0033-1356548. Epub 2013 Sep 13. Review.

PMID:
24037628
19.

[Current aspects of lymphangioleiomyomatosis].

Lacronique J, Urban T.

Rev Pneumol Clin. 1999 Oct;55(5):263-9. Review. French.

PMID:
10637892
20.

Lymphangioleiomyomatosis: a review of the literature.

Hancock E, Osborne J.

Respir Med. 2002 Jan;96(1):1-6. Review.

PMID:
11863203

Supplemental Content

Support Center